CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury …

R Al-Shahi Salman, T Kawahara… - Health technology …, 2012 - researchonline.lshtm.ac.uk
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …
被引用次数：163 相关文章 HTML 版

[引用][C] CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain …

P Perel, R Al-Shahi Salman… - Health Technology …, 2012 - journalslibrary.nihr.ac.uk
Background Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …
[HTML] europepmc.org

[HTML][HTML] CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain …

P Perel, T Kawahara, Z Morris… - Health Technology …, 2012 - europepmc.org
Background Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury-a …

P Perel, RAS Salman, T Kawahara… - Health technology …, 2012 - researchonline.lshtm.ac.uk
Background: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury …

P Perel, RAS Salman, T Kawahara… - Health Technology …, 2012 - research.ed.ac.uk
Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the
risk of death in patients with traumatic bleeding, with no apparent increase in vascular …
[HTML] nih.gov

[HTML][HTML] CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain …

P Perel, RAS Salman, T Kawahara… - NIHR Health …, 2012 - ncbi.nlm.nih.gov
CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial
bleeding study: the effect of tranexamic acid in traumatic brain injury, a nested randomised …

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury …

P Perel, RAS Salman, T Kawahara, Z Morris… - 2012 - pubmed.ncbi.nlm.nih.gov
Background Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …
[HTML] europepmc.org

[HTML][HTML] CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain …

P Perel, T Kawahara, Z Morris… - Health Technology …, 2012 - europepmc.org
Background Tranexamic acid (TXA) has been shown to reduce blood loss in surgical
patients and the risk of death in patients with traumatic bleeding, with no apparent increase …